Zymeworks Inc. (ZYME) stock

ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30141% above fair value

$26.47−2.60 (-8.94%)

Close on Nov 12, 2026Market cap $1.88BP/E 50.9Yield –

Zymeworks profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Zymeworks's profit margin for the twelve months ending Sep 30, 2026 was 16.3%. For fiscal 2025 it was -76.6%, against -160.8% the year before. The highest annual figure on record is 30.1% in fiscal 2022.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-76.6%	+84.2
FY2024	Dec 31, 2024	-160.8%	−4.7
FY2023	Dec 31, 2023	-156.1%	−186.3
FY2022	Dec 31, 2022	30.1%	+824.2
FY2021	Dec 31, 2021	-794.0%	−330.5
FY2020	Dec 31, 2020	-463.5%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	67.7%	+138.7
Q2 FY2026	Jun 30, 2026	-980.8%	−985.6
Q1 FY2026	Mar 31, 2026	-1834.0%	−1750.5
Q4 FY2025	Dec 31, 2025	-1638.5%	−1562.8
Q3 FY2025	Sep 30, 2025	-71.0%	+115.6
Q2 FY2025	Jun 30, 2025	4.8%	+200.6
Q1 FY2025	Mar 31, 2025	-83.5%	+232.1
Q4 FY2024	Dec 31, 2024	-75.8%	+9.8
Q3 FY2024	Sep 30, 2024	-186.6%	−12.8
Q2 FY2024	Jun 30, 2024	-195.8%	+534.7
Q1 FY2024	Mar 31, 2024	-315.6%	−247.1
Q4 FY2023	Dec 31, 2023	-85.6%	−162.4
Q3 FY2023	Sep 30, 2023	-173.8%	+1644.8
Q2 FY2023	Jun 30, 2023	-730.5%	+456.9
Q1 FY2023	Mar 31, 2023	-68.4%	+3722.0
Q4 FY2022	Dec 31, 2022	76.9%	+273.9
Q3 FY2022	Sep 30, 2022	-1818.5%	−440.2
Q2 FY2022	Jun 30, 2022	-1187.4%	–
Q1 FY2022	Mar 31, 2022	-3790.4%	–
Q4 FY2021	Dec 31, 2021	-197.0%	–
Q3 FY2021	Sep 30, 2021	-1378.4%	–